Delisting risk
Medicus Pharma (MDCX)
Develops clinical-stage therapies for skin cancer, urology, oncology, and women’s health.
$0.2600
Pre-market+0.00 (+0.89%)
At close$0.2577(+2.59%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions20 holders · as of Mar 31, 2026 | 3.67% | 2.32M shares | |
| Insiders11 holders · as of Sep 8, 2025 | 10.40% | 6.57M shares | |
| Strategic holders1 holder · as of May 21, 2025 | 10.40% | 6.57M shares | |
| Otherremainder | 75.53% | 47.72M shares |
63.18M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (63.18M in the company's Sep 3, 2026 report, 22.04M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
20 holders · 2.32M shares · 7 new positions · 13 increased · 3 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Interchange Capital Partners, LLC | 1.66M | 2.63% | +75.0K | Apr 24, 2026 |
| Private Advisor Group, LLC | 240.1K | 0.38% | +64.6K | Apr 27, 2026 |
| Virtu Financial LLC | 74.0K | 0.12% | +74.0Knew | May 14, 2026 |
| BRYN Mawr Trust Co | 51.2K | 0.08% | 0 | Apr 30, 2026 |
| May Hill Capital, LLC | 50.6K | 0.08% | +15.0K | May 6, 2026 |
| Commonwealth Equity Services, LLC | 48.1K | 0.08% | +19.7K | Apr 27, 2026 |
| UBS Group AG | 40.4K | 0.06% | +27.2K | May 5, 2026 |
| BlackRock, Inc. | 37.3K | 0.06% | +3.0K | May 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Melani Kenneth R. | 18.20% | 3.25M | 13G | Aug 12, 2025 ↗ |
| Ajay Raju | 16.90% | 2.00M | 13G | Jan 13, 2025 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
